Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied

BREAKING: Stocks Rise, Extending ReboundNovo Nordisk (NVO) stock jumped Wednesday, breathing easily on a lighter-than-feared discount for its semaglutide-based products, Ozempic and Wegovy, under the Inflation Reduction Act.The list, released late Tuesday, includes 15 drugs that will face lower negotiated Medicare prices in 2027. The new prices are 38% to 85% lower than their list prices, and give industry watchers a key view into another avenue the Trump administration is leveraging to lower drug prices.RB ...